|
|
||||||||
| ABSTRACT |
|
|
|---|
(MSP-3
) and the circumsporozoite protein (CSP), we investigated the population diversity of Plasmodium vivax in Mae Sod, Thailand from April 2000 through June 2001. Genotyping the parasites isolated from 90 malaria patients attending two local clinics for the dimorphic CSP gene revealed that the majority of the parasites (77%) were the VK210 type. Genotyping the MSP3-
gene indicated that P. vivax populations exhibited an equally high level of polymorphism as those from Papua New Guinea, a hyperendemic region. Based on the length of polymerase chain reaction products, three major types of the MSP-3
locus were distinguished, with frequencies of 74.8%, 18.7%, and 6.5%, respectively. The 13 alleles distinguished by restriction fragment length polymorphism analysis did not show a significant seasonal variation in frequency. Genotyping the MSP-3
and CSP genes showed that 19.3% and 25.6% of the patients had multiple infections, respectively, and the combined rate was 35.6%. Comparisons of MSP-3
sequences from nine clones further confirmed the high level of genetic diversity of the parasite and also suggested that geographic isolation may exist. These results strongly indicate that P. vivax populations are highly diverse and multiple clonal infections are common in this malaria-hypoendemic region of Thailand. | INTRODUCTION |
|
|
|---|
Malaria epidemiology, as the result of the complex interplay among humans, vectors, and hosts, varies considerably in different geographic regions. Results from extensive research on P. falciparum population structure in the last decade have demonstrated that the parasite populations are highly heterogenetic in both hyperendemic regions and areas where malaria transmission is seasonal. This knowledge has contributed greatly to understanding the dynamics of the disease transmission, which in turn guides our decisions in drug applications and disease control.2,3 The majority of publications on Plasmodium genetic structure focus on P. falciparum, using polymorphic markers such as the merozoite surface protein-1 (MSP-1), MSP-2, glutamate-rich protein, and microsatellites. For P. vivax, only the dimorphic circumsporozoite protein (CSP) gene and the MSP-1 gene have been widely used for genotyping. For example, P. vivax MSP-1 has been used to determine whether a P. vivax infection is the result of a new infection or a relapse.4 Specifically, the P. vivax CSP gene has a central repeat domain that is different in sequence and number of the repeat units.58 Two major types, VK210 and VK247, have a worldwide distribution, with VK210 as the major genotype. Antibodies to P. vivax CSP protein are readily detected in patients from Thailand and neighboring countries.9 For the P. vivax MSP-1 gene, the variable region between interspecies conserved blocks 5 and 6 has been used to genotype P. vivax isolates from many different geographic regions, where at least five types have been discovered.1015 These studies demonstrate the high levels of heterogeneity of P. vivax field populations.
Due to the dimorphic nature of the central repeat region of the P. vivax CSP gene, classifying field isolates into either VK210 or VK247 genotype does not provide a good estimate of the genetic diversity of P. vivax populations. Genotyping the extremely polymorphic P. vivax MSP-1 gene relies almost entirely on sequencing. Therefore, there is a need for the development of other molecular markers that are more suitable for rapid genotyping. One such marker is the MSP-3
gene because its polymorphism can be readily evaluated by polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) analysis.16,17 The MSP-3
gene encodes a merozoite surface protein with an alanine-rich central domain that is predicted to form a coiled-coil tertiary structure.18 Polymerase chain reaction amplification of this gene from field isolates demonstrates product length polymorphism, and digestion of the PCR products with restriction endonucleases indicates the presence of great numbers of alleles.16 In this study, we used the dimorphic P. vivax CSP and MSP-3
markers to evaluate parasite genetic diversity in field P. vivax populations in a hypoendemic area in western Thailand. Our study showed that despite low transmission intensity, the parasites displayed a high level of genetic complexity. In addition, at least 35% of patients had multiple infections by different P. vivax genotypes. Comparisons of MSP-3
sequences from Thai and South American P. vivax isolates suggest substantial geographic variations among parasite isolates.
| MATERIALS AND METHODS |
|
|
|---|
Malaria incidences and association with climatic factors. Data on malaria monthly incidences were collected in two malaria clinics in Mae Sod for the year 2000 and 2001. All the patients exhibiting febrile symptoms were diagnosed with malaria by light microscopy of Giemsa-stained thick blood smears. Three malaria species, P. falciparum, P. vivax, and P. malariae, were distinguished based on morphology by an experienced microscopist. Mixed species infections were further confirmed by a nested PCR using species-specific primer sets designed from ssrRNA genes of the four human malaria species.20 To determine the association between P. vivax incidences with climatic variables, daily temperature and rainfall were obtained from the Surface Data database of the World Meteorological Organization (http://www.ncdc.noaa.gov/oa/climate/climatedata.html). Rainy (April 20October 31) and dry (November 1April 19) seasons were defined based on the daily precipitation data.
Genotyping of P. vivax isolates at the CSP locus. The repeat region of the CSP gene was genotyped for the two major types VK210 and VK247 by PCR and molecular hybridization.5 The PCR amplification of the CSP repeat region was performed as previously described with the following modifications.5 Specimens were denatured for two minutes at 95°C, amplified through 45 cycles for 30 seconds at 95°C, 30 seconds at 45°C, and two minutes at 72°C, and finally incubated for two minutes at 72°C. The CSP genotypes were determined by slot-blot hybridization of the PCR products using the fluorescein-labeled probes derived from the repetitive sequences of either VK210 or VK247 type as previously reported.21
Genotyping of P. vivax isolates at the MSP-3
locus.
Allelic diversity of the MSP-3
gene was studied using the PCR-RFLP method described by Bruce and others.16 The MSP-3
gene was amplified by a nested PCR and 4 µL of the PCR product was isolated by electrophoresis on a 1.0% agarose gel. For RFLP analysis, only Hha I was used for digestion because Alu I did not produce clear restriction patterns in some samples during preliminary analysis. Approximately 5 µL of the PCR product was digested with Hha I and analyzed by electrophoresis on a 1.8% agarose gel. Multiple infections were distinguished when the summed size of the DNA fragments resulting from Hha I digestion exceeded the size of the uncut PCR product.16,17 Major alleles were classified based on the differences in restriction banding patterns. For multiple infections, genotypes of the parasite were assigned to individual allele groups by comparing the RFLP patterns with those of single infections.17
Analysis of MSP-3
gene sequences.
A total of nine PCR products were cloned into the pZero vector (Invitrogen, Carlsbad, CA) and sequenced using the BigDye terminator kit (Applied Biosystems, Foster City, CA). Each PCR product was sequenced in both directions for accuracy. The sequences were assembled and aligned using PILEUP of the Genetics Computer Group (GCG) software, version 10.1 (University of Wisconsin, Madison, WI). The MSP-3
sequence of the Belem strain was used as the reference sequence (accession number AF093584).18 A phylogenetic tree was derived from the aligned nucleotide and deduced amino acid sequences using neighbor-joining method of the Phylogenetic Analysis Using Parsimony (PAUP) program, version 4.0 (University of Washington, Seattle, WA).
Statistical analysis. Association between monthly malaria incidences and climatic variables was analyzed by cross-correlogram. The Chi square test was used to compare the frequencies of individual alleles between the rainy and dry seasons.22
| RESULTS |
|
|
|---|
|
2 = 3.07, degrees of freedom [df] = 1, P > 0.05). Genotyping of the CSP gene showed that 23 of 90 patients (25.6%) had multiple infections with different P. vivax genotypes.
|
gene.
Eighty-eight of 90 malaria samples (97.8%) were successfully amplified for the MSP-3
gene. Based on the size of the PCR products, three major types, A (1.9 kilobases [kb], B (1.5 kb), and C (1.1 kb), were identified (Figure 2
gene because some patients had infections by more than one parasite genotype. Type A, which corresponded to the expected size of the published sequence of the Belem laboratory strain, was the most predominant (74.8%). The other two types, B and C, accounted for 6.5% and 18.7% of the parasite genotypes, respectively. The frequencies of the three MSP-3
types were consistent with those (70.5%, 6.7%, and 22.8%) found in Papua New Guinea.17
|
gene and their frequencies in field parasite populations.
The PCR-RFLP analysis of the MSP-3
gene further demonstrated that P. vivax parasites in western Thailand were highly diverse. The clear restriction patterns produced from digestion with Hha I from the majority of the samples makes this enzyme our prime choice in this study (Figure 2
alleles because the size difference was not easily resolved with our electrophoresis conditions. Smaller bands ranging from 190 to 500 basepairs (bp) were used for RFLP analysis, from which at least 13 allele groups (A1A10, B1, B2, and C) could be identified (Figure 3
2 = 2.69, df = 5, P > 0.05). With this genotyping method, 19.3% of the patients were found to have multiple infections by different P. vivax genotypes, including nine multiple infections not identified by typing of only the P. vivax CSP gene. We must admit that although it was easy to identify multiple infections by this method, it was not possible to always unambiguously assign the multiple isolates to specific allele groups. When genotyping results at these two genetic loci are combined, the multiple infection rate increased to 35.6%.
|
gene sequences.
Nine PCR products (6 Type A, 2 Type B, and 1 Type C) corresponding to nucleotides 2052100 of P. vivax MSP-3
gene of the Belem strain18 were sequenced (Figure 4
gene among individual parasite genotypes in the Mae Sod district. Higher levels of sequence polymorphism were observed in sequences closer to the 5' end of the central alanine-rich domain. Particularly, sequence polymorphism was clustered at nucleotides 298618, 801922, 10751160, and 17271749. Except for the polymorphic region at 17271749, sequences after the deletion of the Type C genotypes were highly conserved. It is noteworthy that most nucleotide substitutions at 17271749 were at the second codon positions, causing amino acid changes. As a result of these nonsynonymous substitutions, the amino acid sequences of this region were dimorphic with either KEATAAKL or TAANVVKD. Analysis of nine MSP-3
gene sequences suggested that the two variant sequences were present equally in the P. vivax field populations from western Thailand.
|
|
| DISCUSSION |
|
|
|---|
gene, we investigated the genetic diversity of P. vivax populations from an area in western Thailand with low malaria endemicity. These results demonstrated that even in areas of low transmission intensities, P. vivax displayed high levels of genetic diversity. With two molecular markers, slight, but not significant, seasonal fluctuations of major parasite genotypes were observed. Moreover, the presence of common alleles in different geographic areas indicated a global distribution of certain parasite genotypes, which may have been maintained through positive selection by hosts. In spite of this, sequence analysis of the MSP-3
gene suggests that some variations might be regionally biased. To determine the distribution of the two P. vivax CSP genotypes VK210 and VK247, multiple surveys have been carried out using both a PCR for genotyping parasites in human blood and an enzyme-linked immunosorbent assay (ELISA) for detecting parasite CSP variants in mosquitoes.2326 The results from these surveys have demonstrated a global distribution of the two P. vivax CSP genotypes in many malaria-endemic regions, although the prevalence of individual genotypes varies geographically. Our previous study using an ELISA on sporozoites produced by feeding mosquitoes on patients infected with P. vivax in Thailand indicates an overall predominance of VK210 (70.5%),23 and the present study by genotyping parasites in human blood showed a similar result, with 78% of the parasites as VK210 type. These results are in sharp contrast to the result of an earlier study in Thailand, in which VK247 was estimated to be the predominant type (83%).25 This difference may be due to sampling biases or temporal fluctuations of individual genotypes. Such a significant decrease over time in the proportions of VK247 has also been observed in a two-year investigation performed in a malaria-hyperendemic area of Papua New Guinea in both the mosquito and human populations.24 This phenomenon may be attributed to selection by host immune pressure on a particular genotype, and/or the preferential production of sporozoites carrying a specific CSP variant in a mosquito species. In a recent study on P. vivax malaria in Mexico, different anopheline mosquitoes were found to be differentially susceptible to infections by VK210 and VK247 variants.27 This explains very well the correlation between the prevalence of two CSP phenotypes with the distribution of different vector species.28 An earlier longitudinal survey over a five-year period23 and this study spanning two seasons both showed seasonal variations in the prevalence of VK210/VK247, although the tendency of this fluctuation was different. Seasonal population dynamics of different mosquito vectors, which are not equally susceptible to infections by VK210 or VK247 parasite isolates, may be one of the factors contributing to this seasonal fluctuation.
The P. vivax MSP-3
gene has been developed as a molecular marker for epidemiologic studies of P. vivax malaria.16 In evaluating genetic diversity and dynamics of the parasite population in asymptomatic patients in Papua New Guinea, Bruce and others17 identified 24 alleles of the MSP-3
gene in P. vivax based on PCR-RFLP analysis using two restriction enzymes. In this study, we identified at least 13 alleles based on Hha I digestion alone, similar to the number of alleles identified by Hha I digestion in the study by Bruce and others.17 This suggests that P. vivax populations in Thailand are equally diverse in spite of the low endemicity of the disease. This seems to contradict the results from studies on P. falciparum, in which a relationship between parasite diversity and transmission intensity has been established.29,30 Many factors may explain such a high level of genetic diversity of the P. vivax parasite. First, some intrinsic biologic properties of the P. vivax malaria such as relapse and early gametocytemia favor the cross-fertilization and meiotic recombination of distinct parasite genotypes within vector mosquitoes. Second, the migration of parasite-carrying foreign workers from Myanmar also adds to the gene pool of the parasite. Third, drug resistance might further affect the duration of infection and enhance genetic recombination in mosquitoes, although there is no clear indication of drug resistance for P. vivax parasite in the study area. Based on the analysis of P. falciparum populations in the same hypoendemic region of Thailand, Paul and others31 argued that the relationship between the genetic structure of the malaria parasite populations and transmission intensity might be nonlinear. The results of our present study further support this argument.
Sequence analysis of the MSP-3
clones identified the regions of deletions for the Type B and C variants. Both variants have deletions close to the N-terminus of the central alanine-rich domain. Inasmuch as both variant types have been found in isolates from other malarial regions, it is reasonable to assume that these deletions are not essential for the survival of the parasite. However, it may have reduced their fitness because the two variants are present in less than 30% of parasite genotypes. Comparing with Type C, Type B has an additional deletion of 26 amino acids upstream of the type C deletion. This portion may be more important than the region of Type C deletion, since less than 6% of parasite genotypes belong to this type. It is noteworthy that the regions with deletions are the most polymorphic, which suggests that this region of the molecule might be selected against by the host immune systems. At present, the limited numbers of MSP-3
gene sequences available would not allow us to perform a detailed phylogenetic comparison of geographically separated clones. However, the fact that a South American clone is more distantly related to the Thai clones suggests that certain degrees of geographic isolation may exist. This preliminary analysis will serve as the foundation for future detailed studies of population structure of P. vivax in different geographic regions.
The multiplicity of malaria infections, i.e., one person simultaneously infected by more than one parasite genotype, is common in endemic areas and particularly high in holoendemic areas. This can arise from co-infection, super-infection, or even somatic mutation during the course of infection. In many African regions with high perennial malaria transmission, the multiplicity of P. falciparum infections can reach very high levels.32 The proportions of multiple P. vivax infections have been estimated in Papua New Guinea, India, Brazil, and Thailand, but it is difficult to compare these values due to differences in sampling and genotyping methods.14,17,23,33,34 However, it could be high in particular cases, since as many as six parasite genotypes have been found in a single host in Papua New Guinea.17 As concluded from this and several earlier studies, using several markers allows the detection of more multiple infections than using a single marker.14 In Papua New Guinea, the combination of MSP-1, CSP, and Duffy antigen binding protein identified multiple infection in 65% of the samples.14 In Thailand, our study using two molecular markers identified 35.6% multiple infections. The difference in multiple infection rates in different malaria-endemic regions may reflect the difference in malaria transmission intensity.29 In Thailand, our current study found that the overall percentage of multiple infections (35.6%) was close to that from our previous study (29.5%),23 but less than the 58% found in an earlier study.25 Furthermore, our result is in sharp contrast to the scarcity of multiple infections found in similarly hypoendemic areas of Sri Lanka using a panel of monoclonal antibodies,35 suggesting that multiplicity of infection is influenced by many factors that differ geographically. Nevertheless, the high levels of parasite population diversity and lack of significant seasonal variations of major parasite alleles suggest that the parasite population structure might be maintained in this hypoendemic area. Therefore, the causes of high parasite heterogeneity and detailed knowledge of malaria epidemiology in this hypoendemic area of Thailand deserve further study.
Received November 21, 2002. Accepted for publication January 9, 2003.
Acknowledgments: We thank Dr. Kuijun Zhao, Christy Pepple, and Jennifer Sommer for their assistance in sequencing some MSP-3
Financial support: This study was partially supported by a grant R01 AI-46472-02S1 from the Research Supplement for Underrepresented Minorities Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health to Liwang Cui, and grants R01 AI-50243 and D43 TW01505 to Guiyun Yan.
clones.
Authors addresses: Liwang Cui, Carlye Mascorro, Qi Fan, and Kimberly Rzomp, Department of Entomology, Pennsylvania State University, 501 ASI Building, University Park, PA 16802, Telephone: 814-863-7663, Fax: 814-865-3048, E-mail: luc2{at}psu.edu. Benjawan Khuntirat and Jetsumon Sattabongkot, Department of Entomology, Armed Forces Institute of Medical SciencesUnited States Army Military Component, Bangkok 10400, Thailand. Guofa Zhou, Hong Chen, and Guiyun Yan, Department of Biological Sciences, State University of New York at Buffalo, Buffalo, NY 14260.
Reprint requests: Liwang Cui, Department of Entomology, Penn-sylvania State University, 501 ASI Building, University Park, PA 16802.
| REFERENCES |
|
|
|---|
This article has been cited by other articles:
![]() |
J. A. BONILLA, L. VALIDUM, R. CUMMINGS, and C. J. PALMER GENETIC DIVERSITY OF PLASMODIUM VIVAX PVCSP AND PVMSP1 IN GUYANA, SOUTH AMERICA Am J Trop Med Hyg, November 1, 2006; 75(5): 830 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Lim, L. Tazi, and F. J. Ayala Plasmodium vivax: Recent world expansion and genetic identity to Plasmodium simium PNAS, October 25, 2005; 102(43): 15523 - 15528. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. COLE-TOBIAN, M. BIASOR, and C. L. KING HIGH COMPLEXITY OF PLASMODIUM VIVAX INFECTIONS IN PAPUA NEW GUINEAN CHILDREN Am J Trop Med Hyg, September 1, 2005; 73(3): 626 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. ZHOU, J. SIRICHAISINTHOP, J. SATTABONGKOT, J. JONES, O. N. BJORNSTAD, G. YAN, and L. CUI SPATIO-TEMPORAL DISTRIBUTION OF PLASMODIUM FALCIPARUM AND P. VIVAX MALARIA IN THAILAND Am J Trop Med Hyg, March 1, 2005; 72(3): 256 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System Antimicrob. Agents Chemother., February 1, 2005; 49(2): 733 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-T. HAN, T.-E. SONG, J.-H. PARK, E.-H. SHIN, S.-M. GUK, T.-Y. KIM, and J.-Y. CHAI ALLELIC DIMORPHISM IN THE MEROZOITE SURFACE PROTEIN-3{alpha} IN KOREAN ISOLATES OF PLASMODIUM VIVAX Am J Trop Med Hyg, December 1, 2004; 71(6): 745 - 749. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |